Literature DB >> 9849055

[Primary biliary cirrhosis: diagnosis and therapy].

J von Schönfeld1, N Breuer, H Goebell.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9849055     DOI： 10.1007/bf03042679

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


× No keyword cloud information.
  9 in total

Review 1.  Heterogeneity of antimitochondrial antibodies.

Authors:  P A Berg; R Klein
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

2.  Serial quantitative liver function tests in patients with primary biliary cirrhosis: a prospective long-term study.

Authors:  J v Schönfeld; N Breuer; R B Zotz; M Beste; H Goebell
Journal:  Digestion       Date:  1997       Impact factor: 3.216

Review 3.  Primary biliary cirrhosis.

Authors:  M M Kaplan
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

4.  Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years.

Authors:  R Klein; G Klöppel; W Garbe; V Fintelmann; P A Berg
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

5.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

Authors:  R E Poupon; K D Lindor; K Cauch-Dudek; E R Dickson; R Poupon; E J Heathcote
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

6.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.

Authors:  K D Lindor; E R Dickson; W P Baldus; R A Jorgensen; J Ludwig; P A Murtaugh; J M Harrison; R H Wiesner; M L Anderson; S M Lange
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

7.  Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study.

Authors:  K Balasubramaniam; P M Grambsch; R H Wiesner; K D Lindor; E R Dickson
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

8.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

Authors:  R E Poupon; R Poupon; B Balkau
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

Review 9.  Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  R H Wiesner; M K Porayko; E R Dickson; G J Gores; N F LaRusso; J E Hay; H E Wahlstrom; R A Krom
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.